Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8196 USD | -0.65% | +2.21% | -89.29% |
05-21 | FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD | CI |
05-08 | Cingulate Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
- Stock Market
- Equities
- CING Stock
- News Cingulate Inc.
- Trading Ideas